Acquired Tertiary MET Resistance (MET D1228N and a Novel LSM8-MET Fusion) to Selpercatinib and Capmatinib in a Patient With KIF5B-RET–positive NSCLC With Secondary MET Amplification as Initial Resistance to Selpercatinib

Autor:	Joanne Xiu, Jian Zhang, Viola W. Zhu, Sai-Hong Ignatius Ou, Shannon S. Zhang, Jeffrey Swensen
Rok vydání:	2021
Předmět:	Pulmonary and Respiratory Medicine Capmatinib Oncogene Proteins business.industry Met amplification Drug resistance medicine.disease Oncology Proto-Oncogene Proteins c-ret Carcinoma Cancer research Medicine Neoplasm business
Zdroj:	Journal of Thoracic Oncology. 16:e51-e54
ISSN:	1556-0864
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::02a6e02d9c49680f4d3633b2d45fab32 https://doi.org/10.1016/j.jtho.2021.03.006 Zobrazit plný text záznamu